Midgard Science

ADViRNA

Worcester, MA, United Statesadvirna.comFrom their website, Nov 2026

Work here? Claim this listing

About

ADViRNA develops and provides oligonucleotide therapeutics services for researchers in academia, biotech, and pharma. It supports projects from target identification and design through synthesis, screening, biodistribution analysis, and preclinical candidate validation. The company is based in Worcester, Massachusetts.

Services

  • Strategic Experimental Planning

    Expert consultation for design, troubleshooting, and delivery strategies.

  • Oligonucleotide Design

    Targeted design services for siRNAs and ASOs, including sequence prioritization and filtering.

  • Oligonucleotide Synthesis

    Custom synthesis of siRNAs, ASOs, and other oligonucleotides with chemical modifications and conjugation options.

  • Oligonucleotide Screening

    High-throughput screening of siRNAs and ASOs to identify potent candidates and validate knockdown.

  • Custom Assay Development

    Development of assays for molecular and functional readouts such as ELISA, western blotting, cell viability, qPCR, and reporter assays.

  • HYBRID-ON™ Oligonucleotide Detection Assay

    Detection and quantification of modified siRNAs and ASOs in complex biological samples.

  • Biodistribution Analysis

    Tissue detection and biodistribution assessment using the HYBRID-ON platform.

  • Precision Data Analysis

    Scientist-curated data outputs from raw values to publication-ready figures.

2 more services
  • In Vivo Study Coordination
  • siRNA Reagents
Turnaround
Most screens are completed within two weeks of receiving materials
What to send
  • Target gene
  • Species
  • Therapeutic modality (siRNA/ASO)
  • Program stage
  • Key constraints or questions

Capabilities

Assays and studies
  • Oligonucleotides
  • In vivo
  • ELISA
  • HTS
  • qPCR
  • Dual-luciferase psiCHECK reporter
4 more
  • Western blotting
  • Cell viability assessment
  • RNA-seq
  • Biodistribution detection
Scale and capacity
  • 1-10 nmol
  • 10-200 nmol
  • 0.2-2 umol
  • 1 to 1000+ candidates
  • 5 nmol
Therapeutic areas
  • Neurological
  • Cardiac
  • Metabolic
  • Oncological
  • Immunological

Instruments and platforms

  • TaqMan
  • Dual-luciferase psiCHECK system

Modalities and species

Modalities
  • Oligonucleotide
  • mRNA
Species and models
  • Human
  • Mouse
  • Rat
  • Rabbit
  • Ocular tissues
  • Primary neurons
  • Cardiomyocytes

Details

Type
CRO
Founded
2007
Address
17 Briden Street, Suite 102 Worcester, MA 01609
Serves
Global

Similar labs